Form D Explorer

Form 1-A — Nok Therapeutics, Inc.

0001213900-24-082240 · filed Sep 26, 2024

Offering

Total offering
—
Total sold
—
Security type
—
Price per security
$2.0000
Over-allotment
—
Jurisdictions
—

Issuer

CIK
2038166
Entity
Corporation
Jurisdiction
FLORIDA
Address
2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066

Most recent fiscal year financials

Financial statement requirements vary by tier and report. Verify the audit or review status in the original SEC filing.

Total assets
$12,000
Total liabilities
$173,363
Cash
—
Total revenues
$0
Net income
$-163,363

Same issuer's Form D filings

View the original filing on SEC EDGAR ↗